Suchergebnisse
10
Alles
Such-Filter
Organisationen
BioAdaptives Inc.
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
13. März 2025 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™....
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
06. Februar 2025 09:25 ET
|
BioAdaptives Inc.
LAS VEGAS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT), a leading biotechnology company focused on innovative health and wellness solutions, proudly announces the...
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors
03. Februar 2025 09:25 ET
|
BioAdaptives Inc.
LAS VEGAS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), a pioneering health and wellness company dedicated to innovative, science-driven solutions, is proud to announce the...
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
21. Januar 2025 14:53 ET
|
BioAdaptives Inc.
LAS VEGAS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT), a forward-thinking innovator in health and wellness solutions, is pleased to announce that FINRA has approved a...
BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health
10. Dezember 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Dec. 10, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT) is thrilled to announce the launch of Xcellara™ Stem Cell Activator, a groundbreaking supplement that harnesses...
BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend
03. Dezember 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) Board of Directors has approved a dividend to all common stockholders. They will receive matching shares for all...
BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™
25. November 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) received approval today for a human clinical trial of its weight management product, Zeranovia™. The trial,...
BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace
21. November 2024 19:09 ET
|
BioAdaptives Inc.
LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James Keener as CEO on May 21, 2024. Previous management retired, and Keener began...
BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions
13. November 2024 09:15 ET
|
BioAdaptives Inc.
LAS VEGAS, Nov. 13, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a leading provider of innovative nutritional products, announces today a transformative shift in its product...
BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split
29. Oktober 2024 17:35 ET
|
BioAdaptives Inc.
LAS VEGAS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- via IBN -- Due to a website maintenance error, a draft of a letter to BioAdaptives® (OTC: BDPT) shareholders was made available on the BioAdaptives®...